According to ChemAnalyst, The Zidovudine Prices recorded an upward movement across major pharmaceutical markets during the second quarter of 2026. Price developments were shaped by firm demand for HIV treatment medicines, higher production costs, fluctuations in energy expenses, and changing raw material economics. Zidovudine, also known as azidothymidine (AZT), remains an established nucleoside reverse transcriptase inhibitor (NRTI) used as part of antiretroviral treatment r